Literature DB >> 22188366

Age at onset in bipolar I affective disorder in the USA and Europe.

Frank Bellivier1, Bruno Etain, Alain Malafosse, Chantal Henry, Jean-Pierre Kahn, Orly Elgrabli-Wajsbrot, Stéphane Jamain, Jean-Michel Azorin, Ellen Frank, Jan Scott, Victoria Grochocinski, David J Kupfer, Jean-Louis Golmard, Marion Leboyer.   

Abstract

OBJECTIVE: To test for differences in reported age at onset (AAO) of bipolar I affective disorder in clinical samples drawn from Europe and the USA.
METHODS: Admixture analysis was used to identify the model best fitting the observed AAO distributions of two large samples of bipolar I patients from Europe and USA (n = 3616 and n = 2275, respectively). Theoretical AAO functions were compared between the two samples.
RESULTS: The model best fitting the observed distribution of AAO in both samples was a mixture of three Gaussian distributions. The theoretical AAO functions of bipolar I disorder differed significantly between the European and USA populations, with further analyses indicating that (i) the proportion of patients belonging to the early-onset subgroup was higher in the USA sample (63 vs. 25%) and (ii) mean age at onset (±SD) in the early-onset subgroup was lower for the USA sample (14.5 ± 4.9 vs. 19 ± 2.7 years).
CONCLUSIONS: The models best describing the reported AAO distributions of European and USA bipolar I patients were remarkably stable. The intermediate- and late-onset subgroups had similar characteristics in the two samples. However, the theoretical AAO function differed significantly between the USA and European samples due to the higher proportion of patients in the early-onset subgroup and the lower mean age-at-onset in the USA sample.

Entities:  

Keywords:  Bipolar I disorder; adolescent; age at onset; precipitating factors; vulnerability factors

Mesh:

Year:  2011        PMID: 22188366     DOI: 10.3109/15622975.2011.639801

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  17 in total

1.  Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States.

Authors:  Robert M Post; Lori L Altshuler; Gabriele S Leverich; Willem A Nolen; Ralph Kupka; Heinz Grunze; Mark A Frye; Trisha Suppes; Susan L McElroy; Paul E Keck; Mike Rowe
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-18

2.  Genetic Risk Score Analysis in Early-Onset Bipolar Disorder.

Authors:  Peter S Jensen; Mark A Frye; Joanna M Biernacka; Paul E Croarkin; Joan L Luby; Kelly Cercy; Jennifer R Geske; Marin Veldic; Matthew Simonson; Paramjit T Joshi; Karen Dineen Wagner; John T Walkup; Malik M Nassan; Alfredo B Cuellar-Barboza; Leah Casuto; Susan L McElroy
Journal:  J Clin Psychiatry       Date:  2017 Nov/Dec       Impact factor: 4.384

3.  Association of Cytomegalovirus and Toxoplasma gondii Antibody Titers With Bipolar Disorder.

Authors:  Mark A Frye; Brandon J Coombes; Susan L McElroy; Lori Jones-Brando; David J Bond; Marin Veldic; Francisco Romo-Nava; William V Bobo; Balwinder Singh; Colin Colby; Michelle K Skime; Joanna M Biernacka; Robert Yolken
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

Review 4.  Juvenile bipolar disorder and suicidality: a review of the last 10 years of literature.

Authors:  Natacha Halfon; Réal Labelle; David Cohen; Jean-Marc Guilé; Jean-Jacques Breton
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-10-07       Impact factor: 4.785

5.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

6.  Age-at-onset subsets of bipolar I disorders: A critical insight into admixture analyses.

Authors:  Claire Montlahuc; Emmanuel Curis; Sarah Flora Jonas; Frank Bellivier; Sylvie Chevret
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-21       Impact factor: 4.035

Review 7.  Understanding Early Age of Onset: a Review of the Last 5 Years.

Authors:  Gabrielle A Carlson; Caroly Pataki
Journal:  Curr Psychiatry Rep       Date:  2016-12       Impact factor: 5.285

8.  Future Directions for Understanding Adolescent Bipolar Spectrum Disorders: A Reward Hypersensitivity Perspective.

Authors:  Lauren B Alloy; Robin Nusslock
Journal:  J Clin Child Adolesc Psychol       Date:  2019-03-25

9.  Categorical and dimensional psychopathology in Dutch and US offspring of parents with bipolar disorder: A preliminary cross-national comparison.

Authors:  Esther Mesman; Boris B Birmaher; Benjamin I Goldstein; Tina Goldstein; Eske M Derks; Marloes Vleeschouwer; Mary Beth Hickey; David Axelson; Kelly Monk; Rasim Diler; Danella Hafeman; Dara J Sakolsky; Catrien G Reichart; Marjolein Wals; Frank C Verhulst; Willem A Nolen; Manon H J Hillegers
Journal:  J Affect Disord       Date:  2016-06-11       Impact factor: 4.839

10.  Common and rare variant analysis in early-onset bipolar disorder vulnerability.

Authors:  Stéphane Jamain; Sven Cichon; Bruno Etain; Thomas W Mühleisen; Alexander Georgi; Nora Zidane; Lucie Chevallier; Jasmine Deshommes; Aude Nicolas; Annabelle Henrion; Franziska Degenhardt; Manuel Mattheisen; Lutz Priebe; Flavie Mathieu; Jean-Pierre Kahn; Chantal Henry; Anne Boland; Diana Zelenika; Ivo Gut; Simon Heath; Mark Lathrop; Wolfgang Maier; Margot Albus; Marcella Rietschel; Thomas G Schulze; Francis J McMahon; John R Kelsoe; Marian Hamshere; Nicholas Craddock; Markus M Nöthen; Frank Bellivier; Marion Leboyer
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.